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Seven patients with critical aortic stenosis underwent aortic valve replace- 
ment with a pulmonary autograft (the Ross operation) between the ages of 
5 weeks and 9 months. The operation was considered mandatory for 
survival because of continued severe heart failure or valve avulsion. Six of 
the patients had undergone unsuccessful previous palliations, such as 
commissurotomy, balloon dilation, and transventricular valvotomy, per- 
formed singly (n = 1) or in combination (n = 5). The other patient with a 
severely hypoplastic aortic valve ring underwent he Ross procedure as a 
primary operation. Two operative deaths occurred. In both cases severe 
endocardial fibroelastosis was detected at autopsy. One late death I year 
after the operation resulted from progressive hypertrophic ardiomyopathy 
and pulmonary hypertension. The rest of the patients are doing well, 
without medications. Apart from trivial regurgitation in two patients, the 
pulmonary autograft is performing well. (J Thorac Cardiovasc Surg 1996; 
112:433-6) 
C ritical aortic stenosis in infancy is associated with high morbidity and mortality 1-3 and necessitates 
urgent intervention for patient survival. If the size of 
the left ventricle is adequate for biventricular repair, 
aortic valve dilation or valvotomy will effectively 
reduce the left ventricular outflow tract (LVOT) 
stenosis in the majority of cases. 4-7 However, some 
patients continue to have severe heart failure be- 
cause of persistent LVOT obstruction or postoper- 
ative aortic regurgitation or because other compli- 
cations related to the primary palliation operation 
develop, making further corrective procedures man- 
datory. Pulmonary autograft replacement, he Ross 
operation, 8 has been used successfully in older chil- 
dren by us and others to replace diseased aortic 
valves. 9-12 Inasmuch as further conservative proce- 
dures were unlikely to succeed in our infants, we 
used this technique as a salvage operation. This 
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report deals with our successes and failures using 
the Ross operation in this uncommon but challeng- 
ing subgroup of patients. 
Patients and methods 
Patients. Six patients with critical aortic stenosis under- 
went primary palliation with transventricular dilation (He- 
gar dilator), open valvotomy, and balloon dilation as 
single operations (n = 3) or as repeated procedures in 
various combinations (n = 3). In one patient, first seen at 
the age of 5 weeks, valve replacement with a pulmonary 
autograft was the primary mode of treatment because of a 
narrow aortic valve ring. All but one were referred for 
treatment within the first days of life and were dependent 
on prostaglandin i fusion for ductal patency and right 
ventricular assistance to maintain adequate systemic ir- 
culation. Despite these measures, four patients continued 
to have severe congestive heart failure, mainly because of 
significant residual stenosis, and needed continuous (n = 
1) or repeated (n = 3) ventilatory support, as well as 
extensive treatment for heart failure. Their critical condi- 
tion made aortic valve replacement mandatory. In two 
patients aortic valve evulsion was a complication of trans- 
ventricular dilation with a Hegar dilator; this damage and 
the risk of aortic dissection were the major reasons for the 
aortic valve replacement. 
Methods. The operation was performed through a 
median sternotomy. Conventional cardiopulmonary b - 
pass with a membrane oxygenator and general hypo- 
thermia to 20°C was used. Both the aorta and the 
pulmonary artery were mobilized before bypass was 
begun. After the initiation of bypass, the aorta was 
crossclamped and cardioplegic solution was infused. 
The aorta was transected and the coronary arteries 
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Table I. Associated anomalies, previous palliations, and clinical status of  patients before the Ross procedure 
Patient EFE PGE 1 Age at primary 
No. Associated anomalies by echo dependent Primary palliation palliation (days) 
1 MR Yes Yes Transventricular dilation 1 
2 COA, PDA, ASD Yes Yes COA repair, transventricular dilation 6 
3 None Yes Yes Transventricular dilation 4 
4 HNCM No Yes Open valvotomy 3 
5 MR No Yes Transventricular dilation 2 
6 None No Yes Transventricular dilation 2 
7 PDA, MR Yes No Ross operation 35 
EFE, Endocardial fibroelastosis; echo, echocardiography; PGE1, prostaglandin El; Ao/Pa, aorta-pulmonary artery size difference; MR, mitral regurgitation; 
CHF, congestive h art failure; COA, coarctation f the aorta; PDA, persistent ductus arteriosus; ASD, atrial septal defect; AR, aortic regurgitation; NA, not 
applicable; HNCM, hypertrophic nonobstructive cardiomyopathy. 
Table I!. Surgical results and follow-up data of  the infants operated on with the Ross procedure 
Patient Follow-up Age at 
No. Clinical status Cause of death (mo) Reoperations reop (mo) 
1 Alive, asymptomatic NA 45 None 
2 Alive, mild CHF NA 44 None 
3 Dead postop. EFE (severe) NA NA 
4 Dead late HNCM, PHT I1 1. Repair of homograft 
2. Left pulmonectomy 
5 Alive, asymptomatic NA 34 None 
6 Alive, asymptomatic NA 31 None 
7 Dead postop. EFE (severe) NA NA 
9 
11 
LVOT, Left ventricular outflow tract; anas., anastomosis, LV, left ventricular; NA, not applicable; AR, aortic regurgitation; MR, mitral regurgitation; CHF, 
congestive h art failure; EFE, endocardial fibroelastosis; PHT, pulmonary h pertension; HNCM, hypertrophic nonobstructive cardiomyopathy. 
were mobilized and resected out of the aorta with a 2 to 
3 mm rim of the aortic wall. The valve and part of the 
valve ring on the anterior side were excised. Because of 
the mismatch between the aorta and the pulmonary 
artery (Table I), a small part of the anterior muscle was 
resected to allow the LVOT to be widened. The suture 
line was reinforced with a pericardial strip in this 
region. Resection of the ventricular septum by the 
Morrow technique ~3 for further widening of the LVOT 
was used in our final five patients. The pulmonary root 
was excised by dividing the main pulmonary artery at 
the bifurcation and proximally by resecting the right 
ventricular outflow tract just below the arteriomuscular 
junction. The pulmonary autograft was trimmed of 
excessive muscle tissue, rotated into position, and su- 
tured to the LVOT with continuous 5-0 Prolene suture 
(Ethicon, Inc., Somerville, N.J.). Two openings were 
created in the vessel wall to accommodate he coronary 
arteries, which were reanastomosed with a continuous 
6-0 PDS suture (Ethicon). After this, we inserted the 
distal suture line in the connection between the pulmo- 
nary artery and an allograft (either aortic or preferably 
pulmonary) with a 6-0 Prolene suture. We then anasto- 
mosed the autograft o the ascending aorta and con- 
nected the allograft centrally to the right ventricular 
outflow tract. A moderate degree of oversizing was 
allowed for the allograft to postpone the problem of 
outgrowing the conduit. The length was adjusted care- 
fully to avoid kinking or stretching. Rewarming was 
continued until the rectal temperature reached 36 o C. 
When the patient was weaned from bypass, hemocon- 
centration was performed until a normal hematocrit 
value was reached. 
Results 
Five patients (71%) survived the operat ion.  Of 
the two pat ients who died, one could not be weaned 
from bypass and the other died after 24 hours with 
the clinical picture of low cardiac output. Extensive 
endocardia l  f ibroelastosis was found at autopsy in 
both these patients. The five survivors were extu- 
bated 2 to 6 days after the operat ion (median 3 
days). Three patients (patients 3, 4, and 5) showed 
rapid improvement and were free of symptoms 
within 1 month. The condit ion of  one deter iorated 
after 2 months, however. The major  prob lem was 
left lung atelectasis, and chronic infection necessi- 
tated left pneumonectomy.  The left ventr icular mass 
cont inued to increase (in the absence of  any residual 
stenosis), suggestive of a pr imary myocardia l  disor- 
der  and secondary pu lmonary hypertension. The 
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Repeated Age at repeated Ventillatory Ao/Pa by Age at Ross 
palliation palliation (days) support (days) Indication for Ross procedure echo (mm) operation (wk) 
Transventricular 15 53 
Open valvotomy 8 52 (2)* 
NA NA NA 
Balloon dilation 66 36 (2) 
NA NA 16 (3) 
NA NA 16 (2) 
NA NA NA 
CHF, MR 6/11 5 
CHF, residual stenosis, AR 6/13.5 7 
CHF, residual stenosis 5/12.5 4 
CHF, residual stenosis, angina pectoris (?) 6.5/12.5 15 
Avulsion of aortic valve, residual stenosis 6/10 22 
Avulsion of aortic valve, AR 6/10 6 
Small aortic diameter 5/9 5 
Echocardiographic evaluation during follow-up 
Aortic valve LVOT Distal anas. L V function Other 
No gradient, trivial AR Mild gradient (16 mm Hg) Laminar flow Normal Trivial MR 
No gradient Mild gradient (14 mm Hg) Laminar flow Impaired diastolic EFE, PHT (rood) 
No gradient, trivial AR Laminar flow Laminar flow Impaired diastolic 
No gradient Laminar flow Laminar flow Normal 
No gradient Laminar flow Laminar flow Normal 
HNCM, PHT (sev) 
child's condition continued to deteriorate, with 
death occurring 1 year after the Ross operation. 
The condition of two other survivors (patients 1 
and 2) improved more slowly. They needed pro- 
longed treatment for congestive heart failure until 2 
years of age.. Endocardial fibroelastosis was diag- 
nosed by echocardiography before the operation in 
both of these patients, and this condition probably 
influenced their slow recovery. 
The pulmonary autograft was found to have trivial 
regurgitation directly after the operation in two of 
our five survivors, but no signs of progression of this 
regurgitation were apparent during follow-up. No 
evidence of stenosis could be detected either at the 
valvular level or at the distal anastomosis. A mild 
projection of the ventricular septum into the LVOT 
was seen in our first two patients, causing a mild 
gradient of 15 mm Hg; this gradient has remained 
unchanged uring 3 years of follow-up. 
Discussion 
Management of critical aortic stenosis is depen- 
dent on the anatomic and functional properties of 
the left ventricle, the aortic valve, and the mitral 
valve. A small left ventricle (inlet length <25 mm), 
narrow aortic valve ring (<5 mm), and small mitral 
valve orifice (<9 mm) make survival after valvotomy 
or dilation procedures unlikely. 3' 14 In these pa- 
tients, either the Norwood procedure or cardiac 
transplantation Should be considered. Likewise, if 
extensive fibroelastosis present, the left ventricle 
will not be able to maintain adequate systemic 
circulation and biventricular epair will fail. Al- 
though assessment of anatomic dimensions i easy, it 
may be impossible to differentiate between over- 
whelming pressure load and endocardial fibroelas- 
tosis as the major cause of left ventricuiar dysfunc- 
tion before the operation. 
In patients with appropriate anatomic dimen- 
sions, survival is influenced by how well the left 
ventricular obstruction s relieved, especially if the 
aortic or mitral valve is incompetent. 14 
Replacement of the aortic valve would effec- 
tively improve the anatomic and functional status 
of the LVOT. The use of allografts in infants is 
limited by the problem of rapid outgrowth of the 
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conduit, however, as well as by the rapid onset of 
degenerative changes and dysfunction of these 
allografts. 14 
On the other hand, the pulmonary autograft has 
the potential to grow, 3' 16, i7 and its durability in 
adults has been documented. 16 These were the 
major reasons for choosing the Ross procedure in 
our infants, whose clinical status necessitated fur- 
ther interventions and whose anatomic and func- 
tional conditions were such that aortic valve replace- 
ment appeared to be the treatment of choice. 
As mentioned earlier, the presence and extent of 
endocardial fibroelastosis is also a major determi- 
nant of the outcome of patients with critical aortic 
stenosis. Fibroelastosis may be present in small, 
contracted cavities, as well as in dilated cavitiesJ 3 
Although thick and generalized endocardial fibro- 
elastosis is expected to cause significant diastolic 
dysfunction, patchy and localized endocardial fibro- 
elastosis may interfere only mildly with left ventric- 
ular performance. Although endocardial fibroelas- 
tosis is more common in patients who do not survive 
surgical treatment, a substantial number of survivors 
do have echocardiographic evidence of endocardial 
fibroelastosis, such as endocardial hyperechogenic- 
ity. We could not clearly differentiate the severely 
thickened endocardium found at autopsy in our two 
nonsurvivors from the endocardial fibroelastosis in 
those who survived, and echocardiography, at least 
in our hands, is not sufficiently specific to indicate 
the severity of the endocardial fibroelastosis. 
The performance of the pulmonary autograft during 
this short-term follow-up is satisfactory, with no signs 
of deterioration. The trivial aortic regurgitation oted 
in two of our patients directly after the operation is 
similar to that seen in patients with transposition in 
whom the arterial switch operation has been used. 
Even though the presence of aortic regurgitation raises 
some concern, no signs of progressive regurgitation 
have been noted during up to 3 years of follow-up in 
our series. Further studies are needed, however, to 
assess the long-term prognosis of the valve. The main- 
tained laminar flow at the distal anastomosis uggests 
that the diameter increases adequately as the child 
grows. Inasmuch as the viability of the pulmonary 
autograft has been verified, 15 such an appropriate 
increase in size may represent active growth. 
In conclusion, we have found the Ross procedure 
useful in the management of infants who have 
critical aortic stenosis suitable for biventricular re- 
pair and in whom other palliative measures failed. 
The complete normalization of the LVOT and 
competent valve function may compensate for re- 
duced left ventricular function and make the Ross 
operation preferable to the Norwood type of sec- 
ondary palliation in this subgroup of critically ill 
patients. 
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